Forte Biosciences (FBRX) Cash from Investing Activities Growth (1y) (2017 - 2025)
Forte Biosciences (FBRX) Cash from Investing Activities Growth (1y) (2017 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Investing Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
-114.28% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
826.39% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
-674.01% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Forte Biosciences |
70.77 Mn |
12.55 Mn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2025 |
604,916.67% |
| Dec 31, 2024 |
-224,818.75% |
| Sep 30, 2020 |
99.98% |
| Jun 30, 2020 |
-2,150.99% |
| Mar 31, 2020 |
108.66% |
| Dec 31, 2019 |
-111.77% |
| Sep 30, 2019 |
-177.25% |
| Jun 30, 2019 |
-151.13% |
| Mar 31, 2019 |
266.54% |
| Dec 31, 2018 |
102.66% |
| Sep 30, 2018 |
-127.45% |
| Jun 30, 2018 |
107.45% |
| Mar 31, 2018 |
-197.08% |
| Dec 31, 2017 |
-515.28% |
| Sep 30, 2017 |
17.72% |
| Jun 30, 2017 |
-228.65% |
| Mar 31, 2017 |
25.16% |
